Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Alefacept plus methotrexate for psoriatic arthritis

Nature Clinical Practice Rheumatology volume 2, pages 470–471 (2006)Cite this article

boxed-textMease PG et al. (2006) Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled study. Arthritis Rheum 54: 1638–1645

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kaltwasser JP et al (2004) Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 50: 1939–1950

    CAS  PubMed  Google Scholar 

  2. Mease PJ et al. (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356: 385–390

    CAS  PubMed  Google Scholar 

  3. Antoni C et al. (2005) Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 64: 1150–1157

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Mease PJ et al. (2005) Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 52: 3279–3289

    CAS  PubMed  Google Scholar 

  5. Papp et al. Efalizumab in patients with psoriatic arthritis: results of a phase 2 randomized double blind placebo controlled study. Presented at International Psoriasis Symposium: 2004 June 10–13; Toronto, Poster 28

  6. Kraan MC et al. (2002) Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis. Arthritis Rheum 46: 2776–2784

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Carole Lovegrove, Freelance Medical Writer.

Author information

Authors and Affiliations

  1. Senior Lecturer at the in the Department of Medicine at the University of Queensland, Rheumatology Research Unit, Australia

    Peter Nash

Authors
  1. Peter Nash
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Nash.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nash, P. Alefacept plus methotrexate for psoriatic arthritis. Nat Rev Rheumatol 2, 470–471 (2006). https://doi.org/10.1038/ncprheum0287

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0287

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing